| Old Articles: <Older 2021-2030 Newer> |
|---|
 |
The Motley Fool
May 25, 2005
W.D. Crotty |
Medtronic's Sneak Preview The medical technology company, a 26-bagger, turns in another strong quarter and fiscal year, then offers quite an outlook.   |
The Motley Fool
May 25, 2005
Karl Thiel |
A Gold Mine in Generics Will NitroMed's new math add up to investment success? |
The Motley Fool
May 25, 2005
Stephen D. Simpson |
Stent Wars 2: The Market-Share Menace The battle for drug-coated stent market share between Johnson & Johnson and Boston Scientific may not be as exciting as watching Obi-Wan Kenobi and Anakin Skywalker fight, but the outcome matters for investors. |
The Motley Fool
May 25, 2005
Tom Taulli |
Genentech's Vision Thing Genentech has been on fire. Now the challenge will be to manage the growth. Investors, take note. |
The Motley Fool
May 25, 2005
Brian Gorman |
Another Deal for Isis Investors shouldn't get their hopes up over the drugmaker's latest collaboration. |
The Motley Fool
May 24, 2005
Charly Travers |
Genentech Eyes a New Market Will Lucentis be the next addition to the biotech giant's growing drug portfolio? Investors, take note. |
BusinessWeek
May 30, 2005
Michael Arndt |
BW 50: A Test Of Zimmer's Agility Artificial joint maker Zimmer Holdings Inc. has the lead in a hot business. But the company faces a Justice probe and price pressures. |
The Motley Fool
May 23, 2005
Jack Uldrich |
Releasing Nanotech's Potential? Recent developments at pSivida suggest a turnaround for the biomedical nanotech company from Down Under. |
The Motley Fool
May 23, 2005
Matt Thurmond |
Steris, Disinfect Thyself The medical technology company needs to sterilize its acquisition strategy. As it is now, Steris is not well-positioned to deliver shareholder value. |
National Defense
June 2005
Robert H. Williams |
High-Tech Gloves Kill Microbes Two U.S. companies--Polygenex International Inc. and Cupron Inc.--have joined forces to produce gloves that kill a full spectrum of dangerous microbes, bacteria and viruses. |
| <Older 2021-2030 Newer> Return to current articles. |
